Initial public offer of up to 22,000,000 equity shares of face value of Rs. 10 each (equity shares) of Syngene International Limited (company or issuer) for cash at a price of Rs. 250 per equity share (including a share premium of Rs. 240 per equity share) (offer price) through an offer for sale by Biocon Limited (the selling shareholder) (offer / offer for sale) aggregating to Rs. 550 crores including a reservation of 2,000,000 equity shares for subscription by Biocon shareholders for cash at a price of Rs. 250 per equity share aggregating up to Rs. 50 crores (the Biocon shareholders reservation portion). The offer will constitute 11.0% of the post-offer paid-up equity share capital and the net offer shall constitute 10.0% of the post-offer paid-up equity share capital. Offer Price : Rs. 250 per Equity share of face value of Rs. 10/- each. The offer price is 25 times of the face value.Anchor investor offer price : Rs. 250 per equity share.